About Scintillam Nutrapeutics Private Limited
Data last updated:
Scintillam Nutrapeutics Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 February 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2022PTC394344. Its GSTIN is 07ABHCS9582J1ZL (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Venkatesh Karthikeyan and Alok Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop 227 2nd Floor Vardhman Fashion Mall Road No. 43 Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹56.48 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹60,945 (net margin 1.1%) and EBITDA of ₹83,948 (EBITDA margin 1.5%).
As per MCA filings, the company has open charges of ₹12 Lakh on record.
For more details, the company can be reached via its website scintillamoralcare.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop 227 2nd Floor Vardhman Fashion Mall Road No. 43 Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Scintillam Nutrapeutics Private Limited
The main business activity of Scintillam Nutrapeutics is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Scintillam Nutrapeutics Private Limited FY 2025 filings available
Scintillam Nutrapeutics Private Limited reported revenue of ₹56.48 Lakh (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Scintillam Nutrapeutics Private Limited
Revenue fell 8% in the latest year. EBITDA fell 18% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Scintillam Nutrapeutics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹83,948 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹60,945 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Scintillam Nutrapeutics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.5% | •••• | •••• | •••• |
| Net Profit Margin | 1.1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Scintillam Nutrapeutics are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Scintillam Nutrapeutics Private Limited
Scintillam Nutrapeutics Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aveza Pharmaceuticals Private Limited | ₹57.37 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Jaipur, Rajasthan, India |
| Arvoni Lifesciences Private Limited | ₹57.03 Lakh (FY 2025) | •••• | •••• | -58.0% | •••• | Zirakpur, Punjab, India |
| Real Pharma India Private Limited | ₹56.8 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Richie Laboratories Limited | ₹56.7 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Guwahati, Assam, India |
| Pharmika India Private Limited | ₹56.61 Lakh (FY 2024) | •••• | •••• | -7.0% | •••• | Delhi, India |
| Scintillam Nutrapeutics Private Limited this company | ₹56.48 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Delhi, India |
| Biogreen Remedies Private Limited | ₹56.43 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Banjarahills, Telangana, India |
| Nimaco Formulations (India) Private Limited | ₹56.37 Lakh (FY 2024) | •••• | •••• | -77.0% | •••• | Ahmedabad, Gujarat, India |
| Deevans Life Care Private Limited | ₹56.29 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Hyderaba, Telangana, India |
| Octis Research Laboratories Private Limited | ₹56.28 Lakh (FY 2018) | •••• | •••• | -86.0% | •••• | Chennai, Tamil Nadu, India |
| Vyden Lifesciences Private Limited | ₹56.22 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Scintillam Nutrapeutics by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Scintillam Nutrapeutics Private Limited
Scintillam Nutrapeutics Private Limited is audited by Das Rakesh And Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Das Rakesh And Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Scintillam Nutrapeutics Private Limited
Scintillam Nutrapeutics has 6 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkatesh Karthikeyan Also directs: Scintillam Solutions (OPC) Private Limited | Director | 27 Jun 2022 | 4 Years 3 Months | Current |
| Alok Sharma | Director | 25 Feb 2022 | 4 Years 7 Months | Current |
| Pinka Bhattacharjee | Director | 25 Feb 2022 | 4 Years 7 Months | Current |
| Debasis Jena | Director | 29 Mar 2025 | 1 Years 6 Months | Current |
| Manoj Chakraborty | Director | 29 Mar 2025 | 1 Years 6 Months | Current |
| Rudra Nath Sinha | Director | 29 Mar 2025 | 1 Years 6 Months | Current |
Ownership and Shareholding of Scintillam Nutrapeutics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Scintillam Nutrapeutics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2024 | Others | ₹12 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Scintillam Nutrapeutics Private Limited
Scintillam Nutrapeutics Private Limited has a workforce of 0 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Scintillam Nutrapeutics Private Limited
Scintillam Nutrapeutics Private Limited has 6 board changes on record since 2022: 6 appointments. The latest: Debasis Jena was appointed as Director on 29 Mar 2025.
Credit Ratings, Litigation & Regulatory Alerts for Scintillam Nutrapeutics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Scintillam Nutrapeutics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Scintillam Nutrapeutics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Scintillam Nutrapeutics Private Limited
Scintillam Nutrapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABHCS9582J1ZL | Delhi | Active | 02 Apr 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Scintillam Nutrapeutics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scintillam Nutrapeutics Private Limited
Scintillam Nutrapeutics is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 February 2022 (4+ years old) and is registered under CIN U24299DL2022PTC394344.
Scintillam Nutrapeutics reported revenue of ₹56.48 Lakh for FY 2025 (down 8% YoY).
Scintillam Nutrapeutics has 6 current directors:
- Venkatesh Karthikeyan - Director
- Alok Sharma - Director
- Pinka Bhattacharjee - Director
- Debasis Jena - Director
- Manoj Chakraborty - Director
- Rudra Nath Sinha - Director
Scintillam Nutrapeutics reported a net profit of ₹60,945 (net margin 1.1%) and EBITDA of ₹83,948 (EBITDA margin 1.5%) for FY 2025, as per its filed financial statements.
The GSTIN of Scintillam Nutrapeutics is 07ABHCS9582J1ZL, registered in Delhi.
The CIN (Corporate Identification Number) of Scintillam Nutrapeutics is U24299DL2022PTC394344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scintillam Nutrapeutics was incorporated on 25 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Scintillam Nutrapeutics by revenue are Aveza Pharmaceuticals Private Limited, Arvoni Lifesciences Private Limited, Real Pharma India Private Limited, Richie Laboratories Limited, Pharmika India Private Limited and 5 more, all in the Pharma industry (Formulations).
Debasis Jena was appointed as Director on 29 Mar 2025. Manoj Chakraborty was appointed as Director on 29 Mar 2025. Rudra Nath Sinha was appointed as Director on 29 Mar 2025. Scintillam Nutrapeutics has 6 board changes on record in total.
Scintillam Nutrapeutics can be reached through the website scintillamoralcare.com. Its registered office is in Delhi, India.
The registered office of Scintillam Nutrapeutics is at Shop 227 2nd Floor Vardhman Fashion Mall Road No. 43 Pitampura, Delhi, India – 110034.